Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for 605016 from our risk checks.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥24.23 |
52 Week High | CN¥30.49 |
52 Week Low | CN¥18.57 |
Beta | 0.47 |
1 Month Change | -12.72% |
3 Month Change | -14.65% |
1 Year Change | 20.25% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 125.61% |
Recent News & Updates
Shareholder Returns
605016 | CN Food | CN Market | |
---|---|---|---|
7D | -5.8% | -2.3% | -4.9% |
1Y | 20.2% | -21.7% | -16.6% |
Return vs Industry: 605016 exceeded the CN Food industry which returned -21.7% over the past year.
Return vs Market: 605016 exceeded the CN Market which returned -16.6% over the past year.
Price Volatility
605016 volatility | |
---|---|
605016 Average Weekly Movement | 6.4% |
Food Industry Average Movement | 6.6% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 11.5% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 605016's share price has been volatile over the past 3 months.
Volatility Over Time: 605016's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 659 | Hongjian Zhuo | https://www.sdblcy.com |
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of functional sugar in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto- oligosaccharide, galacto- oligosaccharide, and xylo- oligosaccharide.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Fundamentals Summary
605016 fundamental statistics | |
---|---|
Market cap | CN¥6.08b |
Earnings (TTM) | CN¥192.99m |
Revenue (TTM) | CN¥868.26m |
31.2x
P/E Ratio6.9x
P/S RatioIs 605016 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
605016 income statement (TTM) | |
---|---|
Revenue | CN¥868.26m |
Cost of Revenue | CN¥643.58m |
Gross Profit | CN¥224.68m |
Other Expenses | CN¥31.69m |
Earnings | CN¥192.99m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 27, 2024
Earnings per share (EPS) | 0.78 |
Gross Margin | 25.88% |
Net Profit Margin | 22.23% |
Debt/Equity Ratio | 3.6% |
How did 605016 perform over the long term?
See historical performance and comparison